Promoting Recovery Optimization With WALKing Exercise After Stroke (PROWALKS)

October 24, 2024 updated by: University of Delaware
Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.

Study Overview

Status

Completed

Conditions

Detailed Description

As a group, stroke survivors are more physically inactive than even the most sedentary older adults. Lack of physical activity has serious consequences in persons with stroke, including an increased risk of recurrent stroke, developing other diseases and mortality. Current rehabilitation interventions do little to improve real-world walking activity after stroke, suggesting that simply improving walking capacity is not sufficient for improving daily physical activity after stroke. Rather, the investigator's hypothesize that the combination of a fast walking intervention that improves walking capacity, with a step activity monitoring program that facilitates translation of gains from the clinic to the "real-world", would generate greater improvements in real world walking activity than with either intervention alone. Data from the investigator's lab provides support for this hypothesis; however, it suggests that the greater efficacy of combining the 2 interventions depends on a participant's initial walking activity. Thus, the investigator's do not expect that one intervention will be superior to the others for all participants, but rather that the combined intervention will be superior for those with low levels of baseline walking activity, speed and endurance. The specific objective of this study is to test whether and for whom combining fast walking training with a step activity monitoring program (FAST+SAM) is superior in improving real-world walking activity compared to fast walking training alone (FAST) or a step activity monitoring and feedback program alone (SAM) in those with chronic stroke. Using a randomized controlled experimental design, 225 chronic (> 6 months) stroke survivors, will complete 12 weeks of fast walking training (FAST), a step activity monitoring program (SAM) or a fast walking training + step activity monitoring program (FAST+SAM). Moderation of specific intervention outcomes by baseline characteristics will be evaluated to determine for whom the interventions are effective.

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19712
        • University of Delaware

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age 21-85
  2. Chronic stroke (>6 months post stroke)
  3. Able to walk at self-selected speed without assistance from another person (assistive devices are allowed)
  4. Self-selected walking speed >0.3 m/s and <1.0 m/s
  5. Average steps/day <8,000
  6. Resting heart rate between 40-100 beats per minute
  7. Resting blood pressure between 90/60 to 170/90.

Exclusion Criteria:

  1. Evidence of cerebellar stroke
  2. Other potentially disabling neurologic conditions in addition to stroke
  3. Lower limb Botulinum toxin injection <4 months earlier
  4. Current participation in physical therapy
  5. Inability to walk outside the home prior to the stroke
  6. Coronary artery bypass graft, stent placement or myocardial infarction within past 3 months
  7. Musculoskeletal pain that limits activity
  8. Inability to communicate with investigators
  9. score >1 on question 1b and >0 on question 1c on the NIH Stroke Scale.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: FAST+SAM
Subjects participate in fast walking training in combination with a step activity monitoring program
Subjects participate in fast walking training plus a step activity monitoring program 3x/week for 12 weeks
Active Comparator: FAST alone
Subjects participate in fast walking training
Subjects participate in fast walking training 3x/week for 12 weeks.
Active Comparator: SAM alone
Subjects participate in a step activity monitoring program
Subjects participate in a step activity monitoring program 3x/week for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Steps Per Day
Time Frame: Change from Baseline to 3 months (Post)
average change in steps per day between two time points, measured over at least a 3-day period for each time point
Change from Baseline to 3 months (Post)
Steps Per Day
Time Frame: Change from 3 months (Post) to 6 months
average change in steps per day between two time points, measured over at least a 3-day period for each time point
Change from 3 months (Post) to 6 months
Steps Per Day
Time Frame: Change from 3 months (Post) to 12 months
average change in steps per day between two time points, measured over at least a 3-day period for each time point
Change from 3 months (Post) to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-minute Walk Test Distance
Time Frame: Change from Baseline to 3 months (Post)
change between two time points in endurance (measured by distance attained on the 6 minute walk test)
Change from Baseline to 3 months (Post)
Six-minute Walk Test Distance
Time Frame: Change from 3 months (Post) to 6 months
change between two time points in endurance (measured by distance attained on the 6 minute walk test)
Change from 3 months (Post) to 6 months
Six-minute Walk Test Distance
Time Frame: Change from 3 months (Post) to 12 months
change between two time points in endurance (measured by distance attained on the 6 minute walk test)
Change from 3 months (Post) to 12 months
Self-selected Gait Speed
Time Frame: Change from Baseline to 3 months (Post)
change between two time points in average self-selected speed on the 10m walk test
Change from Baseline to 3 months (Post)
Self-selected Gait Speed
Time Frame: Change from 3 months (Post) to 6 months
change between two time points in average self-selected speed on the 10m walk test
Change from 3 months (Post) to 6 months
Self-selected Gait Speed
Time Frame: Change from 3 months (Post) to 12 months
change between two time points in average self-selected speed on the 10m walk test
Change from 3 months (Post) to 12 months
Oxygen Consumption
Time Frame: Change from Baseline to 3 months (Post)
change between two time points in average oxygen consumption at ventilatory threshold
Change from Baseline to 3 months (Post)
Oxygen Consumption
Time Frame: Change from 3 months (Post) to 6 months
change between two time points in average oxygen consumption at ventilatory threshold
Change from 3 months (Post) to 6 months
Oxygen Consumption
Time Frame: Change from 3 months (Post) to 12 months
change between two time points in average oxygen consumption at ventilatory threshold
Change from 3 months (Post) to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Darcy Reisman, PT, PhD, University of Delaware

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 18, 2016

Primary Completion (Actual)

January 1, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

July 11, 2016

First Submitted That Met QC Criteria

July 15, 2016

First Posted (Estimated)

July 18, 2016

Study Record Updates

Last Update Posted (Actual)

October 28, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be deposited in the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH) repository.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on FAST+SAM

Subscribe